Data Vantage: Novotech, Carousell’s acquisitions, Coda’s revenue surge and more

The Singapore entity of Sydney-headquartered clinical research and testing company Novotech Health has allotted new shares worth $5 million to US-based NCGS Inc, according to corporate filings reviewed by DealStreetAsia – DATA VANTAGE.

The share allotment followed last week’s announcement of Novotech’s acquisition of NCGS, a privately held contract research organisation (CRO) with a biopharma client base and a workforce of about 300 professionals across the US.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter